Lyrica
Product Images NDC 52959-897

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Lyrica (NDC 52959-897). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (50 mg Capsule Bottle)

Principal Display Panel (50 mg Capsule Bottle)
This is a label of a medication named LYRICA 50mg capsule manufactured by Pfizer. It is a prescription drug and should be used as directed by a doctor. The lot number of the capsule is LYR510PZ, and it was manufactured in Vega Baja, Puerto Rico. The expiration date of the product is 11/12. The NDC number for this capsule is 52959-891-30, and the pill ID is a white round capsule with the number 0071-1013-68. The box contains 30 capsules. The rest of the text seems to be a repetition of this information with some variations and is not very useful.*
FDA Label Image

Principal Display Panel (75 mg Capsule Bottle)

Principal Display Panel (75 mg Capsule Bottle)
This is the label of a bottle of Lyrica 75mg capsules manufactured by Pfizer in Vega Baja, PR with lot number LYCO5PZ and expiration date 08/10. The Rx number is 000000. The pills are white/orange capsules and are only available with a prescription. The label provides caution regarding the transfer of the pill and instructs patients to take as directed by their doctor or to see the enclosed leaflet for usual dosage information. Other text on the label appears to be illegible or a repetition of the information provided.*
FDA Label Image

Principal Display Panel (100 mg Capsule Bottle)

Principal Display Panel (100 mg Capsule Bottle)
This is the packaging information of a medication called LYRICA 100mg Capsule, manufactured by Pfizer and located in Vega Baja, PR. The lot number is LIR104PZ and the expiration date is 10/10. The prescription is only allowed with a valid RX and the usual dosage information can be found on the outsert. The remaining text is not clear and includes gibberish characters.*
FDA Label Image

Principal Display Panel (150 mg Capsule Bottle)

Principal Display Panel (150 mg Capsule Bottle)
This is a description of a prescription drug called Lyrica. The package contains 30 white round capsules with strength of 150mg each. The manufacturer is Pfizer and the lot number is LRC155PZ. It should be taken as directed by a doctor with usual dosage information available on the insert. The text includes a medication guide with the National Drug Code (NDC) 0071-1016-68 and expiration date of 04/10. No information is available about the other text "52959-897-30 RX Only: 10000000 KKK e e e A o e U REREHTBF EABREN Sire i co oy pioce 5107" as it seems unrelated.*
FDA Label Image

Figure (Lyrica 01)

Figure (Lyrica 01)
This appears to be a medical formula for estimating creatinine clearance for female patients. The formula takes into account the patient's age, weight in kilograms, and serum creatinine levels in mg/dL. However, it is difficult to fully understand the formula without additional context or information.*
FDA Label Image

Chemical Structure (Lyrica 02)

FDA Label Image

Figure (Lyrica 03)

FDA Label Image

Figure (Lyrica 04)

FDA Label Image

Figure (Lyrica 05)

FDA Label Image

Figure (Lyrica 06)

FDA Label Image

Figure (Lyrica 07)

Figure (Lyrica 07)
This appears to be a chart or table, displaying information about the percentage of patients who improved with different treatments. It includes the medication Pregatalin (at a dosage of 100 mg and a frequency of 3 times per day), as well as Pregabalin (at an unspecified dosage but a frequency of 3 times per day), and a placebo (called "Placeta"). The last line seems to show the percentage improvement in pain from a baseline measurement. However, the rest of the text is not legible or does not appear to be in English.*
FDA Label Image

Figure (Lyrica 08)

FDA Label Image

Figure (Lyrica 09)

FDA Label Image

Figure (Lyrica 10)

FDA Label Image

Figure (Lyrica 11)

FDA Label Image

Logo (Lyrica 12)

Logo (Lyrica 12)
Distributed by Parke-Davis, Division of Pfizer Inc, NY, NY 10017.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.